Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CTSB | P07858 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11901986 | 0.83 | ALDH1A1 (0.45) | HTTALDH1A1MAPTHPGDKMT2A | |
| Hydrazine SCHEMBL28990400 | 0.78 | PDE10A (0.55) | ALDH1A1MAPTKMT2AMEN1PDE10A | |
| Hydrazine SCHEMBL30355078 | 0.78 | PDE10A (0.55) | ALDH1A1MAPTKMT2AMEN1PDE10A | |
| SCHEMBL294121 | 0.77 | PDE10A (0.58) | HTTALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL5643188 | 0.77 | PDE10A (0.48) | HTTALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL29579675 | 0.77 | PDE10A (0.58) | HTTALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL28984045 | 0.76 | S1PR4 (0.39) | HTTALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL8141010 | 0.75 | HTT (0.37) | HTTALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL799695 | 0.75 | ALDH1A1 (0.51) | HTTALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL251801 | 0.75 | MAPT (0.45) | ALDH1A1MAPTKMT2AMEN1PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120026327-A | Acidic etching solution for aluminum-based circuit | 深圳市溢诚电子科技有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-120006268-A | Leadless high-phosphorus chemical nickel plating solution | 珠海联鼎化工设备有限公司 | 2025-05-16 | — | — | CN | claimed |
| US-20240391874-A1 | NOVEL, SAFE, ECONOMICAL AND AN EFFICIENT PROCESS FOR PREPARATION OF 3-FLUORO-2-NITRO PYRIDINE OF FORMULA I | AASTRID LIFE SCIENCES PVT. LTD. (IN) | 2024-11-28 | — | — | US | claimed |
| CN-117603134-A | Nitration process for pyridine derivatives, process for preparing 2-nitro-3-aminopyridine and intermediates | 上海凌凯医药科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| EP-4251612-A1 | NOVEL, SAFE, ECONOMICAL AND AN EFFICIENT PROCESS FOR PREPARATION OF 3-FLUORO-2-NITRO PYRIDINE OF FORMULA I | Aastrid Life Sciences Pvt. Ltd. (IN) | 2023-10-04 | — | — | EP | claimed |
| WO-2023119308-A1 | NOVEL, SAFE, ECONOMICAL AND AN EFFICIENT PROCESS FOR PREPARATION OF 3-FLUORO-2-NITRO PYRIDINE OF FORMULA I | AASTRID LIFE SCIENCES PVT. LTD. (IN) | 2023-06-29 | — | — | WO | claimed |
| CN-107177588-A | Modified glass bead carrier for fixing Azodrin degradation bacteria and preparation method thereof | 光合强化（北京）生物科技有限公司 | 2017-09-19 | — | — | CN | claimed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| CN-100456398-C | Electrolyte for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORP (JP) | 2009-01-28 | — | — | CN | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-5648496-A | AMINATION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-07-15 | — | — | US | claimed |
| CN-1138033-A | Process for produducing aminonitropyridines | SUMITOMO CHEMICAL CO (JP) | 1996-12-18 | — | — | CN | claimed |
| EP-0735025-A1 | Process for producing aminonitropyridines | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 1996-10-02 | — | — | EP | claimed |
| EP-0188007-B1 | PROCESS FOR THE PREPARATION OF 2-NITRO-3-AMINOPYRIDINE, AND THE N,N'-DI-(2-NITRO-3-PYRIDYL) UREA ITSELF OCCURRING AS AN INTERMEDIATE PRODUCT | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-08-19 | — | — | EP | claimed |
| US-4952697-A | REACTING 3-AMINOPYRIDINE WITH PHOSGENE OR UREA, NITRATING AND HYDROLYSIS | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-08-28 | — | — | US | claimed |
| EP-0149537-B1 | PROCESS FOR THE SYNTHESIS OF AMINONITROPYRIDINES | ELI LILLY AND COMPANY (US) | 1988-07-13 | — | — | EP | claimed |
| EP-0260613-A2 | Imidazopyridine derivatives, their preparation and their use as PAF-antagonists | G.D. Searle & Co. (US) | 1988-03-23 | — | — | EP | claimed |
| EP-0188007-A2 | Process for the preparation of 2-nitro-3-aminopyridine, and the N,N'-di-(2-nitro-3-pyridyl) urea itself occurring as an intermediate product | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-07-23 | — | — | EP | claimed |
| US-4552967-A | Process for the synthesis of intermediates in the preparation of diaminopyridines | ELI LILLY AND COMPANY (US) | 1985-11-12 | — | — | US | claimed |
| EP-0149537-A2 | Process for the synthesis of aminonitropyridines | ELI LILLY AND COMPANY (US) | 1985-07-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391874-A1 | NOVEL, SAFE, ECONOMICAL AND AN EFFICIENT PROCESS FOR PREPARATION OF 3-FLUORO-2-NITRO PYRIDINE OF FORMULA I | AFF1, SCN1B, AFF2 | HTT 3946/4885ALDH1A1 1077/4885MAPT 3357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.